US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist
  • 17.0000
  • +0.0175+0.10%
Close Nov 5 16:00 ET
22.44MMarket Cap-884P/E (TTM)

Pieris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
-97.26%53K
65.28%42.81M
-77.78%1.3M
263.50%19.52M
442.32%20.06M
-82.38%1.94M
-17.56%25.9M
-30.76%5.85M
32.36%5.37M
Operating revenue
--0
-97.26%53K
65.28%42.81M
-77.78%1.3M
263.50%19.52M
442.32%20.06M
-82.38%1.94M
-17.56%25.9M
-30.76%5.85M
32.36%5.37M
Cost of revenue
Gross profit
Operating expense
-74.54%4.18M
-65.26%5.36M
-10.07%55.04M
-51.47%6.78M
2.27%16.43M
10.54%16.41M
-5.49%15.42M
-23.08%61.2M
-23.83%13.97M
-24.47%16.07M
Selling and administrative expenses
-6.50%3.43M
2.86%4.14M
2.80%16.85M
-41.61%2.33M
73.18%6.84M
-10.22%3.66M
-8.13%4.02M
-1.20%16.39M
-2.45%3.99M
-4.43%3.95M
-General and administrative expense
-6.50%3.43M
2.86%4.14M
2.80%16.85M
-41.61%2.33M
73.18%6.84M
-10.22%3.66M
-8.13%4.02M
-1.20%16.39M
-2.45%3.99M
-4.43%3.95M
Research and development costs
-94.76%751K
-90.93%1.22M
-21.10%41.8M
-66.71%4.45M
-29.39%9.6M
19.93%14.33M
-4.56%13.42M
-20.51%52.98M
-12.87%13.38M
-28.24%13.59M
Other operating expenses
----
----
55.81%-3.61M
--0
----
-33.78%-1.58M
4.79%-2.03M
-121.79%-8.17M
-209.68%-3.39M
18.17%-1.47M
Operating profit
-214.53%-4.18M
60.67%-5.3M
65.35%-12.23M
32.55%-5.48M
128.84%3.09M
132.72%3.65M
-153.11%-13.48M
26.68%-35.3M
17.93%-8.13M
37.86%-10.7M
Net non-operating interest income expense
-58.98%201K
-32.77%240K
156.73%1.85M
29.63%455K
127.80%549K
271.21%490K
12,000.00%357K
17,925.00%721K
5,950.00%351K
5,925.00%241K
Non-operating interest income
-58.98%201K
-32.77%240K
156.73%1.85M
29.63%455K
127.80%549K
271.21%490K
--357K
17,925.00%721K
5,950.00%351K
5,925.00%241K
Other net income (expense)
339.75%386K
400.00%171K
-1,186.88%-14.16M
236.31%443K
-2,089.90%-14.39M
-123.82%-161K
-124.89%-57K
-45.80%1.3M
-185.98%-325K
6.64%723K
Special income (charges)
----
----
---13.91M
--981K
---14.89M
----
----
--0
--0
--0
-Less:Impairment of capital assets
----
----
--13.91M
---981K
--14.89M
----
----
--0
--0
--0
Other non- operating income (expenses)
339.75%386K
400.00%171K
-119.19%-250K
-65.54%-538K
-30.01%506K
-123.82%-161K
-124.89%-57K
-45.80%1.3M
-185.98%-325K
6.64%723K
Income before tax
-190.29%-3.59M
62.89%-4.89M
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
Income tax
Net income
-190.29%-3.59M
62.89%-4.89M
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
Net income continuous Operations
-190.29%-3.59M
62.89%-4.89M
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
Minority interest income
Net income attributable to the parent company
-190.29%-3.59M
62.89%-4.89M
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-190.29%-3.59M
62.89%-4.89M
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
Basic earnings per share
-176.03%-2.76
72.08%-3.95
40.00%-21.6
63.64%-3.2
15.38%-8.8
132.41%3.63
-152.68%-14.15
36.62%-36
15.38%-8.8
45.83%-10.4
Diluted earnings per share
-176.24%-2.76
72.08%-3.95
40.00%-21.6
63.64%-3.2
15.38%-8.8
132.32%3.62
-152.68%-14.15
36.62%-36
15.38%-8.8
45.83%-10.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0-97.26%53K65.28%42.81M-77.78%1.3M263.50%19.52M442.32%20.06M-82.38%1.94M-17.56%25.9M-30.76%5.85M32.36%5.37M
Operating revenue --0-97.26%53K65.28%42.81M-77.78%1.3M263.50%19.52M442.32%20.06M-82.38%1.94M-17.56%25.9M-30.76%5.85M32.36%5.37M
Cost of revenue
Gross profit
Operating expense -74.54%4.18M-65.26%5.36M-10.07%55.04M-51.47%6.78M2.27%16.43M10.54%16.41M-5.49%15.42M-23.08%61.2M-23.83%13.97M-24.47%16.07M
Selling and administrative expenses -6.50%3.43M2.86%4.14M2.80%16.85M-41.61%2.33M73.18%6.84M-10.22%3.66M-8.13%4.02M-1.20%16.39M-2.45%3.99M-4.43%3.95M
-General and administrative expense -6.50%3.43M2.86%4.14M2.80%16.85M-41.61%2.33M73.18%6.84M-10.22%3.66M-8.13%4.02M-1.20%16.39M-2.45%3.99M-4.43%3.95M
Research and development costs -94.76%751K-90.93%1.22M-21.10%41.8M-66.71%4.45M-29.39%9.6M19.93%14.33M-4.56%13.42M-20.51%52.98M-12.87%13.38M-28.24%13.59M
Other operating expenses --------55.81%-3.61M--0-----33.78%-1.58M4.79%-2.03M-121.79%-8.17M-209.68%-3.39M18.17%-1.47M
Operating profit -214.53%-4.18M60.67%-5.3M65.35%-12.23M32.55%-5.48M128.84%3.09M132.72%3.65M-153.11%-13.48M26.68%-35.3M17.93%-8.13M37.86%-10.7M
Net non-operating interest income expense -58.98%201K-32.77%240K156.73%1.85M29.63%455K127.80%549K271.21%490K12,000.00%357K17,925.00%721K5,950.00%351K5,925.00%241K
Non-operating interest income -58.98%201K-32.77%240K156.73%1.85M29.63%455K127.80%549K271.21%490K--357K17,925.00%721K5,950.00%351K5,925.00%241K
Other net income (expense) 339.75%386K400.00%171K-1,186.88%-14.16M236.31%443K-2,089.90%-14.39M-123.82%-161K-124.89%-57K-45.80%1.3M-185.98%-325K6.64%723K
Special income (charges) -----------13.91M--981K---14.89M----------0--0--0
-Less:Impairment of capital assets ----------13.91M---981K--14.89M----------0--0--0
Other non- operating income (expenses) 339.75%386K400.00%171K-119.19%-250K-65.54%-538K-30.01%506K-123.82%-161K-124.89%-57K-45.80%1.3M-185.98%-325K6.64%723K
Income before tax -190.29%-3.59M62.89%-4.89M26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M
Income tax
Net income -190.29%-3.59M62.89%-4.89M26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M
Net income continuous Operations -190.29%-3.59M62.89%-4.89M26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M
Minority interest income
Net income attributable to the parent company -190.29%-3.59M62.89%-4.89M26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -190.29%-3.59M62.89%-4.89M26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M
Basic earnings per share -176.03%-2.7672.08%-3.9540.00%-21.663.64%-3.215.38%-8.8132.41%3.63-152.68%-14.1536.62%-3615.38%-8.845.83%-10.4
Diluted earnings per share -176.24%-2.7672.08%-3.9540.00%-21.663.64%-3.215.38%-8.8132.32%3.62-152.68%-14.1536.62%-3615.38%-8.845.83%-10.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data